These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32792323)

  • 1. Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content.
    Boudewyns V; Betts KR; Johnson M; Paquin RS; O'Donoghue AC; Southwell BG
    Res Social Adm Pharm; 2021 Apr; 17(4):733-743. PubMed ID: 32792323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting and Reporting Deceptive Prescription Drug Promotion: Differences Across Consumer and Physician Audiences and by Number and Type of Deceptive Claims and Tactics.
    Betts KR; O'Donoghue AC; Johnson M; Boudewyns V; Paquin RS
    Health Commun; 2022 Nov; 37(13):1609-1621. PubMed ID: 33840305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.
    Faerber AE; Kreling DH
    J Gen Intern Med; 2014 Jan; 29(1):110-8. PubMed ID: 24030427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trust in prescription drug brand websites: website trust cues, attitude toward the website, and behavioral intentions.
    Huh J; Shin W
    J Health Commun; 2014; 19(2):170-91. PubMed ID: 24094133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of deceptive tactics in physician practices: are there differences between international and US medical graduates?
    Lee SY; Dow WH; Wang V; VanGeest JB
    Health Policy; 2004 Mar; 67(3):257-64. PubMed ID: 15036813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deception, intention and clinical practice.
    Colgrove N
    J Med Ethics; 2023 Jul; 49(7):510-512. PubMed ID: 36517228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of deceptive packaging and product involvement on purchase intention: an elaboration likelihood model perspective.
    Lammers HB
    Psychol Rep; 2000 Apr; 86(2):546-50. PubMed ID: 10840911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug information-seeking intention and behavior after exposure to direct-to-consumer advertisement of prescription drugs.
    Liu Y; Doucette WR; Farris KB; Nayakankuppam D
    Res Social Adm Pharm; 2005 Jun; 1(2):251-69. PubMed ID: 17138477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study.
    Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Amoozegar JB; Aikin KJ
    J Health Commun; 2016 Nov; 21(11):1198-1207. PubMed ID: 27805473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Serial Mediation of Deceptive Discount Advertising Effects in Online Retailing.
    van Berlo ZMC; Bock H
    Cyberpsychol Behav Soc Netw; 2023 Jun; 26(6):440-446. PubMed ID: 37140569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Animated Spokes-Characters in Print Direct-to-Consumer Prescription Drug Advertising: An Elaboration Likelihood Model Approach.
    Bhutada NS; Rollins BL; Perri M
    Health Commun; 2017 Apr; 32(4):391-400. PubMed ID: 27315337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay between health claim type and individual regulatory focus in determining consumers' intentions toward extra-virgin olive oil.
    Pichierri M; Pino G; Peluso AM; Guido G
    Food Res Int; 2020 Oct; 136():109467. PubMed ID: 32846553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scoping review of empirical research on prescription drug promotion.
    Giombi K; Thompson J; Wines C; Haughney R; Sullivan HW; Betts KR
    Res Social Adm Pharm; 2023 Jun; 19(6):859-872. PubMed ID: 36931982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Study of the Promotional Implications of Proprietary Prescription Drug Names.
    Peinado S; O'Donoghue AC; Betts KR; Paquin RS; Giombi K; Arnold JE; Kelly BJ; Davis C
    Ther Innov Regul Sci; 2024 Sep; ():. PubMed ID: 39341979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.
    Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Aikin KJ
    J Health Commun; 2017 Feb; 22(2):171-181. PubMed ID: 28129069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Web-Based Consumer Medication Information: Content and Usability of 4 Australian Websites.
    Raban MZ; Tariq A; Richardson L; Byrne M; Robinson M; Li L; Westbrook JI; Baysari MT
    Interact J Med Res; 2016 Jul; 5(3):e21. PubMed ID: 27443680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumer tradeoff of advertising claim versus efficacy information in direct-to-consumer prescription drug ads.
    Aikin KJ; Betts KR; Ziemer KS; Keisler A
    Res Social Adm Pharm; 2019 Dec; 15(12):1484-1488. PubMed ID: 30846370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European consumers and health claims: attitudes, understanding and purchasing behaviour.
    Wills JM; Storcksdieck genannt Bonsmann S; Kolka M; Grunert KG
    Proc Nutr Soc; 2012 May; 71(2):229-36. PubMed ID: 22385589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.